Sunshine Riverhead Capital

阳光融汇资本成立于2015年1月，是中国保险业首批由保险资金发起设立的私募基金管理公司，基金管理规模达300亿元，专注投资于医疗健康、新兴科技领域，投资包括迈瑞医疗、新瑞鹏宠物医疗集团、英盛生物、乐普生物、圣诺制药、硅基仿生、启辰生、赛德阳光、朝聚眼科、宽腾医疗、泰诺麦博、华芯医疗、昆山医源、商汤科技、满帮、青云科技、燧原科技、英韧科技、齐碳科技、创新奇智、摩尔线程、梦之墨等明星企业。 founded in 2015, sunshine riverhead capital is one of the first enterprises offered private fund insurance management which is approved by china insurance regulatory commission. since its inception, riverhead capital has developed according to the market-oriented and professional standards. it has become one of the most outstanding insurance fund management institutions. sunshine riverhead capital includes equity investment, real estate investment, wealth management and other business sectors, with total assets under management of more than 30 billion. 愿景 our vision 让生活更美好 commit to create a better world 使命 our missions 成为“创造价值, 值得信赖”的优秀投资机构 develop a leading investment firm by forging trustworthy, partnership and pursuing constant value creation. 核心价值 core values * 创造价值/ pursue constan